FAECAL CALPROTECTIN AS A DIAGNOSTIC MARKER OF INFLAMMATORY BOWEL DISEASE IN PATIENTS WITH GASTROINTESTINAL SYMPTOMS - IS IT COST-EFFECTIVE PROCEDURE IN PRIMARY CARE IN POLAND?

被引：0
|
作者：
Petryszyn, P. [1 ]
Trznadel, A. [1 ]
Staniak, A. [1 ]
Well, M. [2 ]
Ekk-Cierniakowski, P. [3 ]
机构：
[1] Wroclaw Med Univ, Wroclaw, Poland
[2] Wroclaw Uivers Econ, Wroclaw, Poland
[3] Warsaw Sch Econ, Warsaw, Poland
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.2006
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMD65
引用
收藏
页码：A696 / A696
页数：1
相关论文
共 50 条
  • [1] Faecal calprotectin as a diagnostic marker of inflammatory bowel disease in patients with gastrointestinal symptoms: meta-analysis
    Petryszyn, Pawel
    Staniak, Aleksandra
    Wolosianska, Agnieszka
    Ekk-Cierniakowski, Pawel
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (11) : 1306 - 1312
  • [2] Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms
    Mowat, Craig
    Digby, Jayne
    Strachan, Judith A.
    Wilson, Robyn
    Carey, Francis A.
    Fraser, Callum G.
    Steele, Robert J. C.
    [J]. GUT, 2016, 65 (09) : 1463 - 1469
  • [3] Faecal calprotectin in primary care to screen for inflammatory bowel disease
    Mellis, Craig
    [J]. JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2021, 57 (03) : 458 - 458
  • [4] Faecal calprotectin as a marker of relapse in inflammatory bowel disease - its place in the management algorithm and cost effectiveness in Poland
    Petryszyn, P.
    Wieckowska, N.
    Trznadel, A.
    Ekk-Cierniakowski, P.
    Staniak, A.
    Dudkowiak, R.
    Piotrowski, P.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S178 - S178
  • [5] Cost-effectiveness of faecal calprotectin used in primary care in the diagnosis of inflammatory bowel disease
    Zhang, Wei
    Wong, Chiew Hsia
    Chavannes, Mallory
    Mohammadi, Tima
    Rosenfeld, Greg
    [J]. BMJ OPEN, 2019, 9 (04):
  • [6] NEGATIVE FAECAL CALPROTECTIN TESTING PROVIDES COST-EFFECTIVE DIAGNOSTIC REASSURANCE IN PATIENTS WITH IRRITABLE BOWEL SYNDROME
    Wright, K.
    Kennedy, J.
    Materacki, L. B.
    Waterman, S.
    Makins, R.
    Di Mambro, A.
    [J]. GUT, 2016, 65 : A123 - A124
  • [7] Primary care faecal calprotectin testing in children with suspected inflammatory bowel disease: a diagnostic accuracy study
    Walker, Gareth J.
    Chanchlani, Neil
    Thomas, Amanda
    Lin, Simeng
    Moore, Lucy
    Heerasing, Neel M.
    Hendy, Peter
    Abdelrahim, Mohamed
    Mole, Sean
    Perry, Mandy H.
    Mcdonald, Timothy J.
    Bewshea, Claire M.
    Hart, James W.
    Russell, Richard K.
    Ahmad, Tariq
    Goodhand, James R.
    Kennedy, Nicholas A.
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2020, 105 (10) : 957 - +
  • [8] Diagnostic accuracy and clinical application of faecal calprotectin in adult patients presenting with gastrointestinal symptoms in primary care
    Pavlidis, Polychronis
    Chedgy, Fergus J. Q.
    Tibble, Jeremy A.
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2013, 48 (09) : 1048 - 1054
  • [9] DOES THE PERFORMANCE OF FAECAL CALPROTECTIN TESTING IN PRIMARY CARE DIFFERENTIATE PATIENTS WITH INFLAMMATORY BOWEL DISEASE?
    Conroy, S.
    Hale, M.
    Cross, S.
    Swallow, K.
    Sidhu, R.
    Sargur, R.
    Lobo, A.
    [J]. GUT, 2015, 64 : A25 - A25
  • [10] Faecal calprotectin: a noninvasive marker of disease activity in inflammatory bowel disease
    Bokkers, R. P. H.
    van den Bergh, F. A. J. T. M.
    Kolkman, J. J.
    Russell, M. G. V. M.
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (07) : A1 - A1
12345